Literature DB >> 27022893

Epigenetic regulation in heart failure.

Soo Young Kim1, Cyndi R Morales, Thomas G Gillette, Joseph A Hill.   

Abstract

PURPOSE OF REVIEW: This article provides an overview, highlighting recent findings, of a major mechanism of gene regulation and its relevance to the pathophysiology of heart failure. RECENT
FINDINGS: The syndrome of heart failure is a complex and highly prevalent condition, one in which the heart undergoes substantial structural remodeling. Triggered by a wide range of disease-related cues, heart failure pathophysiology is governed by both genetic and epigenetic events. Epigenetic mechanisms, such as chromatin/DNA modifications and noncoding RNAs, have emerged as molecular transducers of environmental stimuli to control gene expression. Here, we emphasize metabolic milieu, aging, and hemodynamic stress as they impact the epigenetic landscape of the myocardium.
SUMMARY: Recent studies in multiple fields, including cancer, stem cells, development, and cardiovascular biology, have uncovered biochemical ties linking epigenetic machinery and cellular energetics and mitochondrial function. Elucidation of these connections will afford molecular insights into long-established epidemiological observations. With time, exploitation of the epigenetic machinery therapeutically may emerge with clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27022893      PMCID: PMC4955576          DOI: 10.1097/HCO.0000000000000276

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  154 in total

Review 1.  Role of histone acetylation in cell physiology and diseases: An update.

Authors:  Shahper N Khan; Asad U Khan
Journal:  Clin Chim Acta       Date:  2010-06-23       Impact factor: 3.786

2.  Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.

Authors:  Yi Cai; Shan-Shan Yu; Shao-Rui Chen; Rong-Biao Pi; Si Gao; Hong Li; Jian-Tao Ye; Pei-Qing Liu
Journal:  FEBS Lett       Date:  2012-02-20       Impact factor: 4.124

Review 3.  Chromatin remodeling in cardiovascular development and physiology.

Authors:  Pei Han; Calvin T Hang; Jin Yang; Ching-Pin Chang
Journal:  Circ Res       Date:  2011-02-04       Impact factor: 17.367

4.  Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Authors:  Rusty L Montgomery; Thomas G Hullinger; Hillary M Semus; Brent A Dickinson; Anita G Seto; Joshua M Lynch; Christianna Stack; Paul A Latimer; Eric N Olson; Eva van Rooij
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

5.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

7.  Cardiac p300 is involved in myocyte growth with decompensated heart failure.

Authors:  Tetsuhiko Yanazume; Koji Hasegawa; Tatsuya Morimoto; Teruhisa Kawamura; Hiromichi Wada; Akira Matsumori; Yosuke Kawase; Maretoshi Hirai; Toru Kita
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

8.  Inhibition of miR-25 improves cardiac contractility in the failing heart.

Authors:  Christine Wahlquist; Dongtak Jeong; Agustin Rojas-Muñoz; Changwon Kho; Ahyoung Lee; Shinichi Mitsuyama; Alain van Mil; Woo Jin Park; Joost P G Sluijter; Pieter A F Doevendans; Roger J Hajjar; Mark Mercola
Journal:  Nature       Date:  2014-03-12       Impact factor: 49.962

9.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

10.  The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation.

Authors:  Hamid el Azzouzi; Stefanos Leptidis; Ellen Dirkx; Joris Hoeks; Bianca van Bree; Karl Brand; Elizabeth A McClellan; Ella Poels; Judith C Sluimer; Maarten M G van den Hoogenhof; Anne-Sophie Armand; Xiaoke Yin; Sarah Langley; Meriem Bourajjaj; Serve Olieslagers; Jaya Krishnan; Marc Vooijs; Hiroki Kurihara; Andrew Stubbs; Yigal M Pinto; Wilhelm Krek; Manuel Mayr; Paula A da Costa Martins; Patrick Schrauwen; Leon J De Windt
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

View more
  18 in total

1.  DNA methylation dysregulations in valvular atrial fibrillation.

Authors:  Kangjun Shen; Tao Tu; Zhaoshun Yuan; Jiangfeng Yi; Yangzhao Zhou; Xiaobo Liao; Qiming Liu; Xinmin Zhou
Journal:  Clin Cardiol       Date:  2017-08-28       Impact factor: 2.882

2.  Contribution of DNA methylation in chronic stress-induced cardiac remodeling and arrhythmias in mice.

Authors:  Peng Zhang; Tao Li; Ya-Qin Liu; Hao Zhang; Si-Meng Xue; Guang Li; Hai-Ying Mary Cheng; Ji-Min Cao
Journal:  FASEB J       Date:  2019-08-30       Impact factor: 5.191

Review 3.  The genetics of cardiac amyloidosis.

Authors:  Scott Arno; Jennifer Cowger
Journal:  Heart Fail Rev       Date:  2021-09-13       Impact factor: 4.654

4.  DNA methylation in spermatogenesis and male infertility.

Authors:  Xiangrong Cui; Xuan Jing; Xueqing Wu; Meiqin Yan; Qiang Li; Yan Shen; Zhenqiang Wang
Journal:  Exp Ther Med       Date:  2016-08-04       Impact factor: 2.447

5.  Maternal-Fetal Parabiosis in Obesity Exposes Unexpected Roles for Cardiac Metabolism.

Authors:  Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2018-10-17

Review 6.  Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

Authors:  Changhai Tian; Lie Gao; Irving H Zucker
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

Review 7.  Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.

Authors:  Nazha Hamdani; Sarah Costantino; Andreas Mügge; Djamel Lebeche; Carsten Tschöpe; Thomas Thum; Francesco Paneni
Journal:  Eur Heart J       Date:  2021-05-21       Impact factor: 29.983

Review 8.  Mitochondrial Bioenergetics and Dynamism in the Failing Heart.

Authors:  Giampaolo Morciano; Veronica Angela Maria Vitto; Esmaa Bouhamida; Carlotta Giorgi; Paolo Pinton
Journal:  Life (Basel)       Date:  2021-05-12

9.  Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.

Authors:  Soo Young Kim; Xin Zhang; Gabriele G Schiattarella; Francisco Altamirano; Thais A R Ramos; Kristin M French; Nan Jiang; Pamela A Szweda; Bret M Evers; Herman I May; Xiang Luo; Hongliang Li; Luke I Szweda; Vinicius Maracaja-Coutinho; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2020-10-28       Impact factor: 39.918

10.  Hippo pathway deficiency reverses systolic heart failure after infarction.

Authors:  John P Leach; Todd Heallen; Min Zhang; Mahdis Rahmani; Yuka Morikawa; Matthew C Hill; Ana Segura; James T Willerson; James F Martin
Journal:  Nature       Date:  2017-10-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.